The National Institutes of Health (NIH) has announced new funding to support research specifically aimed at celiac disease. A 2017 review showed that celiac disease was the least-funded of all GI disease, and the NIH's last request for funding applications for celiac disease was made 22 years ago. This funding moves us closer to therapies and effective treatments for CD!
This study found that people with CD are more likely to have migraine headaches than those without CD.
This study looked at the prevalence of use of medically unsupervised activated charcoal following gluten ingestion. The study stated that pharmacists should educate patients with celiac disease that there is not sufficient evidence to support the use of activated charcoal.